GlassScriptPhysician profile
Lisa A Smith
NPI 1447647979
$3,371.40
in general payments reported to CMS, 2019-2025
14 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $46.98 · 2021: $35.41 · 2022: $158 · 2023: $199 · 2024: $616 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,168.00 | 2019 | |
| Organogenesis INC. | $234.38 | 2021-2025 | Apligraf, Puraply, Puraply Wound Matrix |
| Kerecis Limited | $193.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Highridge Medical LLC | $165.10 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System, Ebi Osteogen Implantable Bone Growth Stimulator |
| Anika Therapeutics, INC. | $158.22 | 2022 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Stryker Corporation | $106.60 | 2023-2025 | Citrefix, Ortholoc 3di, Augment Injectable |
| Amgen INC. | $53.16 | 2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $46.98 | 2020 | |
| Smith+Nephew, INC. | $40.90 | 2021-2025 | Grafix Pl |
| Averitas Pharma INC. | $30.47 | 2024 | Qutenza |
| Nevro Corp. | $20.24 | 2024 | Senza |
| Integra Lifesciences Corporation | $14.29 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $14.29 | 2024 | Portfolio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.